Business Description
![Mydecine Innovations Group Inc Mydecine Innovations Group Inc logo](https://static.gurufocus.com/logos/0C0000APSX.png?14)
Mydecine Innovations Group Inc
NAICS : 325411
SIC : 3741
ISIN : CA62849F2008
Compare
Compare
Traded in other countries / regions
MYCO.Canada0NF0.GermanyMYCOF.USAMYIG.UK IPO Date
2018-11-05Description
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1.46 | |||||
Debt-to-Equity | -0.84 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 66 | |||||
3-Year EPS without NRI Growth Rate | 43.8 | |||||
3-Year FCF Growth Rate | 34.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.61 | |||||
9-Day RSI | 57.83 | |||||
14-Day RSI | 54.54 | |||||
6-1 Month Momentum % | 34.62 | |||||
12-1 Month Momentum % | -86.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -181.4 | |||||
Shareholder Yield % | -464.85 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -591.31 | |||||
ROIC % | -2990.05 | |||||
ROC (Joel Greenblatt) % | -14061.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.25 | |||||
EV-to-EBITDA | -0.25 | |||||
EV-to-Forward-Revenue | 0.74 | |||||
EV-to-FCF | -1.05 | |||||
Earnings Yield (Greenblatt) % | -403.51 | |||||
FCF Yield % | -692.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mydecine Innovations Group Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.436 | ||
Beta | -0.89 | ||
Volatility % | 178.67 | ||
14-Day RSI | 54.54 | ||
14-Day ATR (€) | 0.00363 | ||
20-Day SMA (€) | 0.008475 | ||
12-1 Month Momentum % | -86.64 | ||
52-Week Range (€) | 0.0015 - 0.151 | ||
Shares Outstanding (Mil) | 61.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mydecine Innovations Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mydecine Innovations Group Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mydecine Innovations Group Inc Frequently Asked Questions
What is Mydecine Innovations Group Inc(STU:0NF0)'s stock price today?
The current price of STU:0NF0 is €0.01. The 52 week high of STU:0NF0 is €0.15 and 52 week low is €0.00.
When is next earnings date of Mydecine Innovations Group Inc(STU:0NF0)?
The next earnings date of Mydecine Innovations Group Inc(STU:0NF0) is .
Does Mydecine Innovations Group Inc(STU:0NF0) pay dividends? If so, how much?
Mydecine Innovations Group Inc(STU:0NF0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |